Castle Creek Biosciences buys gene therapy company weeks after canceling IPO plans
January 10, 2022 at 14:55 PM EST
The deal will enable the Exton company to expand both its new product pipeline and its technology platform.
|
||||||||||||
![]() |
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Events | Directory | Real Estate | Blog | More
|